Inventor
PINNEY KEVIN G
US21 patents
⚠️ This page may combine multiple inventors who share the name “PINNEY KEVIN G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BAYLOR
11 patentsUS5886025AMar 23, 1999
Anti-mitotic agents which inhibit tubulin polymerization
UNIV BAYLOR56 citations96
US6162930ADec 19, 2000
Anti-mitotic agents which inhibit tubulin polymerization
UNIV BAYLOR80 citations94
US6350777B2Feb 26, 2002
Description anti-mitotic agents which inhibit tubulin polymerization
UNIV BAYLOR36 citations90
US6919324B2Jul 19, 2005
Functionalized stilbene derivatives as improved vascular targeting agents
UNIV BAYLOR19 citations89
US6593374B2Jul 15, 2003
Tubulin binding ligands and corresponding prodrug constructs
UNIV BAYLOR22 citations89
US7429681B2Sep 30, 2008
Combretastatin analogs with tubulin binding activity
UNIV BAYLOR10 citations79
US7456214B2Nov 25, 2008
Chromene-containing compounds with anti-tubulin and vascular targeting activity
UNIV BAYLOR7 citations69
US7001926B2Feb 21, 2006
Tubulin binding agents and corresponding prodrug constructs
UNIV BAYLOR10 citations69
US7091240B2Aug 15, 2006
Tubulin binding ligands and corresponding prodrug constructs
UNIV BAYLOR3 citations58
US10807932B2Oct 20, 2020
Benzosuberene analogues and related compounds with activity as anticancer agents
UNIV BAYLOR0 citations44
US7893261B2Feb 22, 2011
Serotonin reuptake inhibitors
UNIV BAYLOR1 citations39
OXIGENE INC
6 patentsUS7384925B2Jun 10, 2008
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC6 citations70
US8877967B2Nov 4, 2014
Compositions and methods for inhibition of cathepsins
OXIGENE INC4 citations68
US6956054B2Oct 18, 2005
Compositions and methods for use in targeting vascular destruction
OXIGENE INC4 citations62
US9458103B2Oct 4, 2016
Compositions and methods for inhibition of cathepsins
OXIGENE INC2 citations56
USRE45907EMar 1, 2016
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC0 citations49
USRE45720EOct 6, 2015
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC0 citations49